House Rx

San Francisco, United States

House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

$55.0M raised

Nov 2025

Series B

Top Investors

Bessemer Venture PartnersKhosla VenturesTown Hall VenturesNew Enterprise AssociatesMaverick Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has House Rx raised?

House Rx has raised $55.0M in total funding. The most recent round was Series B. The last funding was announced in November 2025.

Who are House Rx's investors?

House Rx's investors include Bessemer Venture Partners, Khosla Ventures, Town Hall Ventures, New Enterprise Associates, Maverick Ventures.

Where is House Rx headquartered?

House Rx is headquartered in San Francisco, United States.

What does House Rx do?

House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

What stage is House Rx at?

House Rx is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 12, 2025.

MLA

"House Rx — Funding & Investors." VCBacked, November 12, 2025, https://www.vcbacked.co/company/house-rx. Accessed June 3, 2026.

APA

VCBacked. (2025). House Rx — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/house-rx

Wikipedia (cite web)

{{cite web |title=House Rx — Funding & Investors |url=https://www.vcbacked.co/company/house-rx |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 12, 2025.